FRIDAY, NOVEMBER 24, 2017

University of Freiburg researchers find C. difficile molecular docking site

A team of researchers from the University of Freiburg recently identified which molecular docking site binds with C. difficile, a dangerous intestinal bacterium that causes both diarrhea and life-threatening intestinal infections -- even after long-term antibiotic treatment. Read More »

Antibody response linked to decreased mother-to-child HIV transmission

Despite wide access to drug regimens and therapies that can interrupt transmission, an estimated 250,000 HIV infections each year worldwide are mother-to-child. Read More »

Illinois Department of Public Health furthers tuberculosis investigation

According to a recent announcement, the Illinois Department of Public Health (IDPH) has chosen to further its investigation of potential exposure to extensively drug-resistant tuberculosis (XDR TB). Read More »

MIT investigates better methods for preventing and responding to flu outbreaks

Researchers from MIT recently published a paper that evaluates the best methods of reducing the likelihood of contracting the flu by regularly using non-pharmaceutical interventions (NPIs) and effectively deploying the vaccine. Read More »

Creative Diagnostics unveils custom antibody production service

Creative Diagnostics, a worldwide diagnostics product and service supplier, recently announced its launch of a custom antibody production service, which uses DNA immunization technology. Read More »

SAVSU Technologies unveils special shipping container for Ebola vaccine

SAVSU Technologies, based in Santa Fe, New Mexico, said Tuesday it has created a specialized, high performance, small volume vaccine shipping container called CryoQ to safely transport temperature-sensitive vaccines through hot environments that do not have access to reliable refrigeration. CryoQ trials show that it is capable of consistently maintaining a temperature of 70 degrees below zero C, which is necessary for transporting Ebola vaccine candidates to regions affected by the Ebola outbrea Read More »

Common antibiotic may solve multidrug-resistant bacterial infections

A team of scientists from the University of California, Skaggs School of Pharmacy and Pharmaceutical Sciences and San Diego School of Medicine announced that azithronmycin, a common antibiotic, may solve multidrug-resistant bacteria concerns. Read More »

Researchers begin Phase II trial for diabetes reversing vaccine

Researchers from the Massachusetts General Hospital recently received approval from the U.S. Food and Drug Administration (FDA) to begin a Phase II clinical trial to test a generic vaccine’s ability to reverse advanced Type 1 diabetes. Read More »

Biosantech reports HIV vaccine candidate is safe

Scientists from Biosantech Co., a private company based in France, recently announced that its HIV vaccine candidate is safe and not toxic for HIV patients. Read More »

Trials show single-dose HPV vaccine may prevent cervical cancer

Two trials recently demonstrated that a single dose of the bivalent human papillomavirus (HPV) vaccine Cervarix, created by the GlaxoSmithKline group, may provide just as much protection against HPV-16/18 infections as the traditional schedules for two and three doses, researchers said Wednesday. HPV-16/18 infections are responsible for approximately 70 percent of cervical cancer cases.  "Our findings question the number of HPV vaccine doses truly needed to protect the majority of women against Read More »

Researchers make new observations of retrovirus capsid

Researchers from the Institut Pasteur in Montevideo collaborated with the Uruguayan medical school to make an important discovery about the capsid of a retrovirus. The scientists learned that the native retroviral capsid is flexible. Read More »

Indiana expands investigation of TB cases

Professionals from the Indiana State Department of Health have collaborated with the Floyd and Clark county health departments to investigate a tuberculosis (TB) case in southern Indiana. Read More »

Southeastern Indiana HIV outbreak update: 166 confirmed cases

Indiana state health professionals have released the latest update on the HIV outbreak in Indiana. There are now 169 cases of HIV; 166 of these cases have been confirmed, with three potential patients testing preliminary positive. Read More »

WHO reports progress toward eliminating measles in South-East Asia Region

Health professionals from the World Health Organization (WHO) South-East Asian Region have recently reported significant progress toward eliminating measles. Read More »

Gavi to heighten engagement with countries transitioning into Vaccine Alliance

The Vaccine Alliance recently announced a series of actions that will support the new goals of the Alliance’s 2016-20 strategy, and the Gavi Board has chosen to assist the countries making the transition into the new practices. Read More »

Global Stop TB Partnership begins online consultation

The Stop Tuberculosis (TB) Partnership recently started its online consultation process that will engage large groups of stakeholders in further developing the Global Plan to Stop TB 2016-2020. Read More »

Hong Kong updates number of dengue fever patients

The Hong Kong's Centre for Health Protection (CHP) recently released an update about the nation's number of dengue fever cases. Read More »

EpiVax receives investments toward new Q fever vaccine

EpiVax recently received $5.2 million in investments from the Defense Threat Reduction Agency (DTRA) for creating a new vaccine to prevent Q fever. Read More »

Nordic companies form immuno-oncology firm

A partnership has formed between Targovax and Oncos Therapeutics as they invest significant financial contributions and collaborate to form a Nordic leader in the immuno-oncology field. Read More »

HHS exploring quick, easy test for Ebola infections

The U.S. Department of Health and Human Services’ (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) said Friday it will continue to pursue the development of a fast, easy diagnostic test for Ebola that it can be used in hospitals, doctor’s offices, clinics or field settings. The new diagnostics test, called OraQuick, provides test results within just 20 minutes, making it the fastest Ebola test yet. Read More »